id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-D-0187-0021,FDA,FDA-2000-D-0187,"Guidance for Industry:  Recommendations for Donor Questioning, Deferral, Reentry, and Product Management to Reduce the Risk of Transfusion-Transmitted Malaria; Availability",Notice,Notice of Availability,2013-08-19T04:00:00Z,2013,8,2013-08-19T04:00:00Z,,2013-08-19T14:42:09Z,2013-19962,0,0,09000064813b8a55
FDA-2000-D-0187-0022,FDA,FDA-2000-D-0187,"Recommendations for Donor Questioning, Deferral, Reentry and Product Management to Reduce the Risk of Transfusion-Transmitted Malaria:  Guidance for Industry",Other,Guidance,2013-08-01T04:00:00Z,2013,8,2013-08-01T04:00:00Z,,2022-12-08T15:47:42Z,,0,0,09000064813b9117